Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma
Open Access
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 84 (5) , 582-587
- https://doi.org/10.1038/labinvest.3700077
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancerAnnals of Oncology, 2003
- Targeting epidermal growth factor receptor—are we missing the mark?The Lancet, 2003
- Expression of the HER1–4 family of receptor tyrosine kinases in breast cancerThe Journal of Pathology, 2003
- A strong intronic enhancer element of the EGFR gene is preferentially active in high EGFR expressing breast cancer cellsJournal of Cellular Biochemistry, 2000
- Prognostic Factors in Breast CancerArchives of Pathology & Laboratory Medicine, 2000
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer?Breast Cancer Research and Treatment, 1994
- Structure and expression of c‐erbB‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: Prognostic significanceInternational Journal of Cancer, 1989
- PREDICTIVE VALUE OF EGF RECEPTOR IN BREAST CANCERThe Lancet, 1988
- Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cellsCell, 1987